Perivascular Fat Inflammation: From Atherosclerosis to COVID-19, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will provide an overview of the role of inflammation in the pathophysiology of atherosclerosis and coronary artery disease. They will also discuss the role of perivascular adipose tissue as a biomarker of coronary inflammation, as well as the impact of COVID-19 on vascular inflammation.

Xtalks Life Science Webinars

The biology of adipose tissue inflammation also offers unique insights into a variety of diseases, ranging from diabetes to COVID-19.

Vascular inflammation is a critical factor in both atherosclerotic plaque formation and subsequent plaque rupture. The role of inflammation in atherosclerosis has recently gained further prominence with clinical trials such as CANTOS and COLCOT, showing that reducing systemic inflammation improves clinical outcome. There is now an increased focus on targeting residual coronary inflammatory risk as a viable therapeutic target in cardiovascular drug development.

Currently, available tests for the detection of coronary artery inflammation are either non-specific for the cardiovascular system (e.g., plasma biomarkers) or expensive and not readily available (e.g., hybrid positron emission tomography imaging). Novel methods for the non-invasive quantification of coronary inflammation, through analysis of changes in perivascular adipose tissue attenuation (or radiodensity) in coronary computed tomography angiography, allow us to overcome many of the limitations of existing biomarkers and could be a valuable tool for the quantification of residual inflammatory risk, cardiovascular risk stratification and evaluating the treatment effect of novel anti-inflammatory therapies.

The biology of adipose tissue inflammation also offers unique insights into a variety of diseases, ranging from diabetes to COVID-19.

This field of scientific research has been pioneered by Professor Charalambos Antoniades, who is a Deputy Head of the Division of Cardiovascular Medicine at the University of Oxford and Chairman-Elect of the British Atherosclerosis Society. He will provide an overview of the field and its applicability to enable the design of precision cardiovascular trials.

Join Dr. Charalambos Antoniades along with Dr. Cheerag Shirodaria, Vice President Cardiovascular Medicine, Covance, Honorary Consultant Cardiologist, Oxford University Hospitals NHS Foundation Trust for the live webinar on Monday, September 28, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Perivascular Fat Inflammation: From Atherosclerosis to COVID-19.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website